Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted ...
Abbott (NYSE:ABT) today shared new clinical trial findings supporting its Aveir AR leadless atrial pacemaker system.
NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, ...
Patients, ≥18 years of age, were eligible for inclusion if they had at least one PAF episode documented by electrocardiogram (ECG) and a properly functioning Vitatron DDDR pacemaker with a bipolar ...
Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...
Harish Manyam, MD, chief of cardiology at Erlanger and Chair of Medicine for the University of Tennessee Health Science Center College of Medicine – Chattanooga, completed Tennessee’s first atrial ...
The Aveir DR dual-chamber leadless pacemaker system (Abbott) performs well out to 1 year in patients largely treated for sinus node dysfunction or atrioventricular (AV) block, according to extended ...
Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.
The rhythm is regular at a rate of 120 beats/min. A pacemaker stimulus occurs before each QRS complex (→). This is ventricular pacing. Because the pacing rate is 120 beats/min, the mode of pacing must ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results